baber/WOPTO huggingface dataset:
Patent CN-100510679-C (CN)
Title: 一种行星轮轴承试验装置
Inventor: HONGWU LI
IPC: G01M13/04
Filed: 2007-08-24
Granted: 2009-07-08
Abstract: 本发明属于轴承试验装置，具体涉及一种行星轮轴承试验装置。本发明通过与另一电机相连的另一输入轴驱动另一输入齿轮，另一输入齿轮驱动第二加载小齿轮，第二加载小齿轮再驱动大齿轮，大齿轮带动连接盘，连接盘驱动齿圈，从而实现直接改变齿圈的转速，直接改变自转和公转转速比，从而在不同自转和公转转速比下实现对行星轮轴承的疲劳寿命试验。由于不需要更换不同齿轮传动比的行星排来实现自转和公转转速比的变化，因此本发明降低了成本，缩短了试验时间。
Patent CN-100550656-C (CN)
Inventor: CHENGCHAO ZHENG
IPC: H04L1/00
Filed: 2007-12-27
Granted: 2009-10-14
Abstract: 公开了信道译码方法、装置和低密度奇偶校验码译码器，属于编解码技术领域。所述信道译码方法包括：初始化变量节点，根据所述变量节点的初始化结果进行校验节点更新处理，根据所述校验节点更新处理结果、修正函数进行所述变量节点更新处理，所述修正函数为：φ(x)＝log(e x +n)/(e x -1)，其中：-1＜n＜1；根据所述变量节点的初始化结果、所述变量节点更新处理结果进行译码处理。相对于现有的SPA译码而言，本发明能够在不增加译码运算量的情况下，在一定程度上避免信道噪声方差估计不准对SPA译码性能的影响，从而提高了译码性能的稳定性。
Patent CN-100573372-C (CN)
Title: 构建全方位移动装置运动模型的方法及设备
Inventor: RONG XIONG
IPC: G05B17/02
Filed: 2008-09-22
Granted: 2009-12-23
Abstract: 本发明提出一种构建全方位移动装置运动模型的方法及设备，其构建全方位移动装置运动模型的方法包括以下步骤：控制全方位移动装置按照预先设定的运动参数进行平动，并记录下全方位移动装置各个全方位轮的速度；控制全方位移动装置按照预先设定的运动参数进行转动，并记录下全方位移动装置各个全方位轮的速度；根据全方位移动装置在平动与转动过程中质心的运动信息以及所记录的各个全方位轮的速度，分别建立全方位移动装置在平动与转动方向上的全方位轮到质心运动的传递矩阵；拟合全方位移动装置平动及转动方向上的全方位轮到质心运动的传递矩阵，形成全方位移动装置的运动模型。通过本发明可以建立任意全方位移动装置的运动模型。
Patent CN-100588710-C (CN)
Inventor: SHUHAI LIU
IPC: A23K10/38
Filed: 2008-09-19
Granted: 2010-02-10
Abstract: 本发明提供了一种从木薯发酵制备乙醇的废液中回收固体残渣的方法，该方法包括对废液进行固液分离，其中，在对废液进行固液分离之前在废液中加入水溶性海藻酸酯和/或水溶性海藻酸盐。通过本发明提供的方法显著地缩短了固液分离的时间，在无需增加新设备的情况下显著地提高了单位时间内废液的处理量，从而解决了导致木薯发酵制备乙醇的装置的运行负荷较低的瓶颈，提高了木薯发酵制备乙醇的装置的生产能力。
Patent FR-70862-E (FR)
IPC: G01N27/414
Filed: 1956-12-14
Granted: 1959-09-02
Abstract: 842,897. Discharge tubes. GENERAL ELECTRIC CO. Dec. 20, 1956 [Dec. 20, 1955], No. 38875/56. Class 39(1). In a vapour detector in which the atmosphere containing the substance to be detected is passed between a negative collector electrode and a heated positive emitter electrode supported on a ceramic core, and the positive ion current is measured, positive ion emitting material containing an alkali metal glass is interposed between the core and the emitter electrode to supply positive ions when detecting substances such as halogen compounds which have an ionization potential higher than the work function of the emitter electrode surface. The detector shown comprises a cylindrical core 12 of ceramic material preferably having a high alumina content supported on two rods 16 and 17 which are retained in openings 10b and 10c in the end wall of a ceramic housing 10, which end wall also has openings 10d and 10e through which vapour may enter or be discharged. A heater coil 13, e.g. of an alloy of 90% platinum and 10% rhodium, is wound on the core 12 with one end 18 wrapped around the rod 16 and the other end 20 wrapped around the rod 17, and is buried in a coating 15 of positive ion emitting material containing an alkali metal glass known as B-eucryptite (Li2O Al2O3. 2SiO2). A cylindrical emitter electrode 14, preferably of platinum, surrounds and is in contact with the coating 15 and is connected to the rod 16 by a strap 23. A cylindrical collector electrode 24, preferably of platinum, is maintained with its upper flared end 24a engaging a shoulder 10g in the housing 10 by a ceramic washer 25 having a plurality of sloping fingers 25a which engage the lower end of the electrode. The washer 25 is held in engagement with a shoulder 10h by bent portions 16a and 17a of the rods 16 and 17 which are secured to bolts 21 and 22 mounted in a flange 10a at the open end of the housing 10 and forming terminals for the heater coil 13. A conductor 26 having one or two turns 26a wrapped around the electrode 24 is spaced from the electrode 24 and is bent at the end and secured to a terminal bolt 27. The construction is such that the heat loss from the emitter and collector electrodes is kept to a minimum. The emitter electrode attains a temperature between 700 and 925‹C.
Patent PT-1183551-E (PT)
Inventor: FERRETTI ALESSANDRO
IPC: G01S13/90
Filed: 2000-04-20
Abstract: Process for radar measurements of movements of city areas and landsliding zones, characterised in that permanent scatterers are identified through the analysis of N-1 differential interferograms with respect to the same image (master), using a reference digital elevation model (DEM) with vertical precision better that 50 meters. For every pixel of the image selected on the satistical properties of the modulus of the reflectivity, a temporal series of the interferometric phases is generated. Then, differences among temporal series that belong to neighboring pixels are formed (differential temporal series). For every differential temporal series, the linear phase components are calculated in relation to the baseline and the phase components connected to the displacement model, already known, in relation to the time. The relative error between the precise elevation of the pixel and that supplied from the reference DEM is associated with the linear phase component of the differential temporal series in relation to the baseline.
Patent PT-1274687-E (PT)
Inventor: CLOZEL MARTINE
IPC: A61P43/00
Filed: 2001-03-12
Abstract: The invention relates to novel 1,2,3,4-tetrahydroisochinoline derivatives of formula (I) and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as orexin receptor antagonists.
Patent PT-1221874-E (PT)
Inventor: BOUIX HERVE F
IPC: A45D40/26
Filed: 2001-07-20
Abstract: A disc-type cosmetic applicator has a plurality of individual discs connected by integrally molded springs to yield a single disc array. The space between the individual discs of the disc array is compressible during withdrawal from a container so that excess product can be removed from the applicator by a wiper. After passage through the wiper, the springs between the individual discs are biased to return to the array to a fully expanded position. The compressing of the discs during withdrawal allows a controlled amount of product to remain on the applicator for application by the consumer, and the returning of the discs to their expanded position by the spring causes the discs to assume a configuration which allows the applicator to effectively comb and separate the eyelashes. The single unit construction of the multi-disc array allows efficient and convenient assembly of a complete applicator by securing a single disc array to a conventional applicator stem with a simple pin.
Patent PT-1294910-E (PT)
Title: Protein glycosylation modification in pichia pastoris
Inventor: CONTRERAS ROLAND
IPC: C12N5/10
Filed: 2001-06-29
Abstract: The present invention provides genetically engineered stains of  Pichia  capable of producing proteins with reduced glycosylation. In particular, the genetically engineered strains of the present invention are capable of expressing either or both of an ±-1,2-mannosidase and glucosidase II. The genetically engineered strains of the present invention can be further modified such that the OCH1 gene is disrupted. Methods of producing glycoproteins with reduced glycosylation using such genetically engineered strains of  Pichia  are also provided.
Patent PT-1328379-E (PT)
Title: Knife-sharpening machine
Inventor: STALLEGGER HARALD
IPC: B24D15/08
Filed: 2001-10-10
Abstract: The invention relates to a knife sharpening machine comprising a plate-type holding device on which two intersecting sharpening bars are rotationally mounted and loaded in relation to each other by means of springs. The sharpening bars, at least in the grinding area, are made of a ceramic material. The plate is provided with a slit which is open on one end and closed on the other, extending as far as the intersection point of the sharpening bars. When pressure is exerted by the knife in the direction of the closed slit end, the sharpening bars are spread apart from each other counter to the force of the springs. Curved guides are provided on both sides of the slit. The ends of the sharpening bars, facing away from the axes of rotation thereof, are guided therein.
Patent PT-1337553-E (PT)
Title: Nucleic acid vaccine comprising a fusion protein including an adjuvant sequence from a plant viral coat protein
Inventor: SAVELYEVA NATALIA
IPC: C07K14/08
Filed: 2001-11-20
Abstract: A nucleic acid construct is provided for delivery into living cells in vivo for inducing an immune response in a patient to an antigen; the construct directing the expression of a fusion protein, said fusion protein comprising said antigen and an adjuvant sequence derived from a plant viral coat protein. Methods for making constructs and methods of using such constructs for the treatment of infectious disease, cancer and B cell malignancy, are provided.
Patent PT-1380212-E (PT)
Title: Casing film for food
Inventor: MORI NOBUYUKI
IPC: B65D65/02
Filed: 2002-04-10
Abstract: The present invention provides a casing film for food which is moderately permeable to watervapor andmoderately impermeable to oxygen and that can be subjected to smoking treatment and can retain the scent, color and flavor of smoked food. The present invention also provides a casing film for food that can be applied to, in addition to smoked food, unsmoked dry sausage, dry ham, etc. <??>The casing film for food is characterized in that it comprises a mixture of polyvinylpyrrolidone and thermoplastic resin. The thermoplastic resin is preferably a polyamide resin. The mixing ratio of the polyamide resin to polyvinylpyrrolidone is preferably 50 to 99:50 to 1 by weight, and more preferably 80 to 99:20 to 1 by weight.
Patent PT-1490263-E (PT)
Title: Method and apparatus for loading a container with a product
Inventor: BAILEY THOMAS W
IPC: B65B1/38
Filed: 2003-04-03
Abstract: There is provided a method of loading a container with a defined quantity of product comprising closing off a perforation in a perforated plate; directing powder into the closed-off perforation by the sweeping action of a first director blade spaced from said perforated plate; and transferring the contents of the perforation to said container. The method is characterized by relative rotary motion of the perforated plate and said first director blade. Suitable apparatus is also provided.
Patent PT-1513493-E (PT)
Title: Analgesics
Inventor: MICHIOKA HIDEKAZU
IPC: A61P5/24
Filed: 2003-03-19
Abstract: Aqueous formulations suitable for intranasal administration comprise buprenorphine or a physiologically acceptable salt or ester thereof and (a) a pectin having a degree of esterification of less than 50%, (b) chitosan and a polyoxyethylene-polyoxypropylene copolymer (poloxamer) or (c) chitosan and hydroxypropylmethylcellulose. Such formulations can induce rapid and prolonged analgesia when delivered intranasally to a patient. The buprenorphine or buprenorphine salt or ester may be delivered to the bloodstream to produce within 30 minutes a therapeutic plasma concentration of buprenorphine, C ther , of 0.2 ng/ml or greater which is maintained for a duration T maint  of at least 2 hours.
Patent PT-1499280-E (PT)
Title: Use of beta-cyclodextrine with surfatants as a pearly-lustring agent
Inventor: MULLER RAINER
IPC: A61K8/00
Filed: 2003-04-17
Abstract: A pearl luster composition (A) comprises an aqueous medium containing at least one surfactant (I) and at least one cyclodextrin (or its derivative) (II), where (I) and (II) are present at sufficient concentrations to create a pearl luster effect and/or to form an insoluble complex.  Independent claims are included for the use of (II) as: (i) pearl luster and/or opacifying agents, specifically in compositions comprising an aqueous medium containing (I); (ii) as agents for suspending insoluble conditioner(s) in cosmetic compositions including and aqueous medium; and (iii) for providing a pearl luster or improving the pearl luster in compositions containing (I).
Patent PT-1572745-E (PT)
Title: Antibody anti human nogo a and its pharmaceutical use
Inventor: SCHWAB MARTIN E
IPC: C07K14/47
Filed: 2003-12-09
Abstract: This invention relates to molecules, such as for example monoclonal antibodies or Fab fragments thereof, which are capable of binding to the human NogoA polypeptide or human NiG or human NiG- or human NogoA_623-640 with a dissociation constant, 1000 nM; polynucleotides encoding such a binding molecule; an expression vector comprising such polynucleotides; the use of such a binding molecule in the treatment of nerve repair, a pharmaceutical composition comprising such a binding molecule; and to a method of treatment of diseases associated with nerve repair.
Patent PT-1608569-E (PT)
Title: Single-dose plastic capsule for powdered coffee and the like
Inventor: ZANETTI MARTINO
IPC: B65D81/00
Filed: 2003-11-05
Abstract: Single-dose capsule comprising a sealed moulded-plastic casing (10) having an end wall (16) provided with orifices (24) and a bottom sealing foil (17). A chamber (30) is formed between the said foil (17) and the bottom surface (18) of the perforated end wall (16) and is filled with the beverage percolated through the said orifices (24) before it is discharged directly towards an underlying container through the spout created at the moment of opening or tearing of the said bottom foil (17), immediately before the start of percolation. USE: preparation of a percolated of the beverage. ADVANTAGES: high quality of the beverage.
Patent PT-1648001-E (PT)
Title: Voltage transformer for railroad locomotive
Inventor: BROCKMANN OLAF
IPC: H01F27/02
Filed: 2004-10-15
Abstract: The transformer has a pressure resistant housing that is provided with pressure relief units at its upper side. A pressure relief unit (9) is provided in a lower area of the housing, where the pressure relief unit (9) enables elusion of gases under pressure in lateral directions or upwards. The unit (9) has a pressure relief channel (5), leading away laterally from the housing, with a pressure relief valve.
Patent PT-1694870-E (PT)
Title: Primers and probes for detecting genital hpv genotypes
Inventor: BATTENFELD KURT
IPC: C12Q1/70
Filed: 2004-12-07
Abstract: Oligonucleotides (ON) that can be used as primers for amplification of nucleic acid regions of genital human papilloma virus (HPV), are new. Oligonucleotides (ON) that can be used as primers for amplification of nucleic acid regions of genital human papilloma virus (HPV) are new. Specifically they have sequence comprising 25 nucleotides (SEQ ID No.:1), especially for use as forward primer, and sequence comprising 23 nucleotides (SEQ ID No.:7), especially for use as reverse primer 5'-CARGC(I or N)AAAWWWKTDAARGAYTGT (SEQ ID No.:1) 5'-ARYGGYTSYARCCAAAARTGRCT (SEQ ID No.:7) where R = A or G; W = T or A; K = T or G; I = inosine; N = A,T,G or C; D = A, T or G; Y = C or T and S = C or G. Independent claims are also included for: (1) oligonucleotide (ON1) useful as probe for detection and/or determination of genital subtypes of HPV having any of 24 sequences reproduced; (2) specified mutant of ON or ON1; (3) oligonucleotides (ON2) having a sequence that is complementary to ON or ON1 over its entire length; (4) primer pair for amplification of a nucleic acid region of a genital HPV comprising at least one ON or ON1, or their specified mutants; (5) nucleic acid (NA1) comprising at least one region of ON1 (or its mutants or complements) plus one or more additional regions of at least one nucleotide (nt); (6) nucleic acid (NA2) that is complementary to NA1 over its entire length; (7) amplifying a region of genital HPV, present in a biological sample, that uses at least one each of forward and reverse primers as defined; (8) detecting/determining a genital HPV genotype by hybridization with ON1, its mutant or complement; (9) array for detecting/determining the genotype of HPV that contains the new oligonucleotides and/or nucleic acids that contain them; and (10) kit for detecting/determining the genotype of a genital HPV containing any of the new primers, primer pairs or probes.
Patent PT-1754707-E (PT)
Title: Multicyclic compounds and their use as inhibitors of parp, vegfr2 and mlk3 enzymes
Inventor: BIHOVSKY RON
IPC: C07D243/00
Filed: 2001-05-09
Abstract: The present invention is directed to novel multicyclic molecules that mediate enzymatic activity. In particular, the compounds may be effective in the treatment of diseases or disease states related to the activity of PARP, VEGFR2, and MLK3 enzymes, including, for example, neurodegenerative diseases, inflammation, ischemia, and cancer.
Patent PT-1787284-E (PT)
Title: Device and method for robustly classifying audio signals, method for establishing and operating audio signal database and a computer program
Inventor: HERRE JUERGEN
IPC: H04H60/31
Filed: 2005-07-21
Abstract: An apparatus for producing a fingerprint signal from an audio signal includes a means for calculating energy values for frequency bands of segments of the audio signal which are successive in time, so as to obtain, from the audio signal, a sequence of vectors of energy values, a means for scaling the energy values to obtain a sequence of scaled vectors, and a means for temporal filtering of the sequence of scaled vectors to obtain a filtered sequence which represents the fingerprint, or from which the fingerprint may be derived. Thus, a fingerprint is produced which is robust against disturbances due to problems associated with coding or with transmission channels, and which is especially suited for mobile radio applications.
Patent PT-1799253-E (PT)
Title: Multivalent canine vaccines against leptospira bratislava and other pathogens
Inventor: FRANTZ JOSEPH
IPC: A61K39/02
Filed: 2005-09-23
Abstract: This invention relates to vaccines and methods for protecting dogs against disease caused by Bordetella bronchiseptica. This invention relates to vaccines and methods for protecting dogs against disease caused by Leptospira bratislava. This invention also relates to combination vaccines and methods for protecting dogs against disease or disorder caused by canine pathogens, for example, infectious tracheobronchitis caused by Bordetella bronchiseptica, canine distemper caused by canine distemper (CD) virus, infectious canine hepatitis (ICH) caused by canine adenovirus type 1 (CAV-1), respiratory disease caused by canine adenovirus type 2 (CAV-2), canine parainfluenza caused by canine parainfluenza (CPI) virus, enteritis caused by canine coronavirus (CCV) and canine parvovirus (CPV), and leptospirosis caused by Leptospira bratislava, Leptospira canicola, Leptospira grippotyphosa, Leptospira icterohaemorrhagiae or Leptospira pomona.
Patent PT-1836680-E (PT)
Title: Method for improved image segmentation
Inventor: ZAHNISER MICHAEL
IPC: G06T5/00
Filed: 2006-01-10
Abstract: An improved image segmentation algorithm is provided that identifies each object in an image. Pixels of the image are sorted based on a range of attribute values of the image. These pixels are then added to a labeling image one by one starting with an extreme point in the range of attribute values. Features are calculated for each object located and these features are matched with pre-defined acceptance criteria. If there is a match, the object is output to an output image. The steps of adding pixels to the image, evaluating the features of the resulting objects and outputting the objects are repeated until a stopping point is reached.
Patent PT-2008974-E (PT)
Title: Cleaning water purification system
Inventor: HAALLBERG MATS
IPC: A47L11/38
Filed: 2007-06-29
Abstract: The present invention relates to the provision of water having a conductivity of 3 ¼S/cm or less, comprising prefiltering (2) inlet water for removal of particulate solids, pumping the prefiltered water and subjecting it to deionization by reverse osmosis (5) and ion exchange (6) treatment. The deionized water is collected in an air-free tank (7) from which the water having a conductivity of 3 ¼S/cm or less may be obtained.
Patent PT-2021275-E (PT)
Title: Enhanced process for the purification of anyhydrous hydrogen chloride gas
Inventor: HALLENBERGER KASPAR
IPC: C01B7/07
Filed: 2007-04-30
Abstract: The present invention relates to a process for purifying anhydrous hydrogen chloride gas ("aHCl"), and preferably the anhydrous hydrogen chloride gas recovered from an isocyanate production process. In the process of the present invention, the content of chlorinated organics may be reduced from up to 1000 ppm by volume to below 10 ppb by volume levels. Generally, the process of the invention allows for chlorinated organic levels to be reduced to from 1 to 100 ppb, rendering the treated hydrogen chloride gas usable in a catalytic oxychlorination process or a Deacon process. The treated gas is also suitable for absorption in water or dilute hydrochloric acid.
Patent PT-662137-E (PT)
Inventor: KUFE DONALD W
IPC: A61K41/00
Filed: 1993-09-08
Abstract: The present invention provides a DNA molecule comprising a radiation responsive enhancer-promoter operatively linked to an encoding region that encodes at least one polypeptide. An encoding region can comprise a single encoding sequence for a polypeptide or two or more encoding sequences encoding DNA binding, activation or repression domains of a transcription factor. Processes for regulating polypeptide expression and inhibiting tumor growth using such DNA molecules are also provided.
Patent PT-757677-E (PT)
Inventor: WALKER KEITH A M
IPC: C07D233/84
Filed: 1995-04-25
Abstract: The present invention relates to novel benzocycloalkylazolethione compounds of formula (I) in which n is 0, 1 or 2; t is 0, 1, 2 or 3; R<1> is independently halo, hydroxy or (C1-4)alkyloxy; and R<2> is attached to the  alpha ,  beta  or  gamma -position and is a group selected from formulae (a), (b) and (c) which are dopamine  beta -hydroxylase inhibitors in which the benzocycloalkyl portion of the compound is selected from indanyl, 1,2,3,4-tetrahydronaphthalenyl and 6,7,8,9-tetrahydro-5H-benzocycloheptenyl (in which the benzo is optionally substituted with one to three substituents) and the azolethione portion of the compound is selected from 2-thioxo-2,3-dihydro-1H-imidazol-3-yl, 5-thioxo-4,5-dihydro-1H-[1,2,4]triazol-4-yl and 5-thioxo-4,5-dihydro-1H-[1,2,4]triazol-1-yl (each optionally substituted with one to three substituents); and the prodrugs, pharmaceutically acceptable salts, individual isomers and mixtures of isomers and the methods of using and preparing such benzocycloalkylazolethione compounds.
Patent PT-786455-E (PT)
Inventor: SUGIMOTO HIROHIKO
IPC: A61P31/18
Filed: 1995-09-25
Abstract: An imidazole derivative represented by general formula (I) or a salt thereof, having the effect of specifically inhibiting the growth of HIV as a pathogenic virus and being reduced in toxicity. In said formula R<1> represents hydrogen, C1-C20 alkyl, C2-C7 alkenyl, C4-C12 cycloalkylalkyl, etc.; R<2> represents C1-C6 alkyl, C1-C6 acyl, hydroxyiminomethyl, hydrazonomethyl or -(CH2)n-R<4> (R<4> being halogeno, alkoxy, hydroxy, etc.; and n being an integer of 1 to 3); R<3> represents substituted or unsubstituted C1-C6 alkyl; X and Y represent each independently hydrogen, C1-C3 alkyl, halogeno, or nitro; and Z represents S, SO, SO2 or CH2. <CHEM>
Patent PT-779031-E (PT)
Inventor: TUZZIO PAUL V
IPC: A21C11/10
Filed: 1996-12-06
Abstract: Material, for example food material, is extruded through an extrusion die and cut into individual portions by a cutter blade which reciprocates across the die. A hot air blower device directs hot air against the cutter blade to prevent the food material, e.g., pretzel dough, from adhering to or accumulating on the cutter blade, thereby reducing machine down time caused by the need to periodically stop and clean the cutter blade. The hot air blower device receives cool air which is passed through the hot air tools and expelled as hot air by a fan-shaped nozzle disposed opposite the cutter blade. <IMAGE>
Patent PT-858345-E (PT)
Inventor: CORTESE RICCARDO
IPC: C12N15/01
Filed: 1996-08-22
Abstract: Cytokines, including muteins thereof, which are biologically inactive in humans but remain immunogenic, are used in pharmaceutical compositions to promote a neutralizing immune response against native cytokines when administered to a subject in need thereof to treat homeostatic disorders and disorders associated with an overproduction of cytokines.